Outset Medical, Inc.
OM
$4.56
$0.122.70%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 120.07M | 119.30M | 115.27M | 113.69M | 114.73M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 120.07M | 119.30M | 115.27M | 113.69M | 114.73M |
| Cost of Revenue | 74.22M | 75.23M | 73.28M | 74.24M | 78.76M |
| Gross Profit | 45.85M | 44.08M | 41.99M | 39.45M | 35.97M |
| SG&A Expenses | 89.31M | 92.80M | 100.17M | 109.18M | 118.20M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 185.46M | 192.72M | 202.59M | 218.55M | 238.11M |
| Operating Income | -65.39M | -73.42M | -87.32M | -104.86M | -123.38M |
| Income Before Tax | -87.18M | -97.51M | -113.37M | -127.49M | -140.33M |
| Income Tax Expenses | 619.00K | 397.00K | 444.00K | 491.00K | 607.00K |
| Earnings from Continuing Operations | -87.80 | -97.90 | -113.82 | -127.98 | -140.94 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -87.80M | -97.90M | -113.82M | -127.98M | -140.94M |
| EBIT | -65.39M | -73.42M | -87.32M | -104.86M | -123.38M |
| EBITDA | -60.52M | -68.17M | -81.75M | -99.14M | -117.61M |
| EPS Basic | -13.00 | -20.02 | -28.94 | -37.05 | -41.28 |
| Normalized Basic EPS | -6.43 | -10.80 | -16.35 | -21.53 | -24.67 |
| EPS Diluted | -13.00 | -20.02 | -28.94 | -37.05 | -41.28 |
| Normalized Diluted EPS | -6.43 | -10.80 | -16.35 | -21.53 | -24.67 |
| Average Basic Shares Outstanding | 46.08M | 31.78M | 17.50M | 13.85M | 13.69M |
| Average Diluted Shares Outstanding | 46.08M | 31.78M | 17.50M | 13.85M | 13.69M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |